Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTO.L Regulatory News (CTO)

  • There is currently no data for CTO

Director/PDMR Shareholding

27 Mar 2024 14:00

RNS Number : 5605I
TClarke PLC
27 March 2024
 

TClarke plc("the Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company announces that on 27th March 2024, the following Executive Directors of the Company were granted nil cost conditional share awards over ordinary shares of 10p each in Company ("Shares") pursuant to the TClarke 2021 Long-term Incentive Plan ("the Plan") as follows:

Executive Director:

Number of conditional shares awarded:

Mark Lawrence

383,478

Mike Crowder

326,877

Trevor Mitchell

287,668

No consideration was paid for the grant of the conditional share awards. The conditional share awards will normally vest on 27th March 2027, being the third anniversary of the date of grant, and will be subject to continued employment with the Company.

50% of the award will be subject to satisfaction of the earnings per share performance condition as set out below:

Annual growth in EPS above CPI*

Proportion of award vesting

Less than 3%

Nil

3%

25%

Between 3% and 10%

Between 25% and 100% on a straight-line basis

Above 10%

100%

*Base point from which performance is measured is based on average EPS for the three years ended 31st December 2023. Earnings per share calculated by profit before tax divided by weighted average of number of shares in issue during the financial year.

50% of the award is being made to incentivise the achievement of the Company's 3 year ambitious organic growth plan, achievement of which would substantially enhance earnings per share. This element of the award will be subject to satisfaction of the Total Shareholder Return (TSR) performance condition as set out below:

TSR*

Proportion of award vesting

Less than 35%

Nil

35%

25%

Between 35% and 50%

Between 25% and 100% on a straight-line basis

Above 50%

100%

 

* Base point share price 150p. The share price at maturity is the 3-month average to 31 December 2026.

Formal notifications in respect of the conditional share awards to the Executive Directors are below;

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Mark Lawrence

2

Reason for the notification

a)

Position/status

Group Chief Executive Officer and Executive Director (PDMR).

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

TClarke plc

b)

LEI

213800OIP8MU517BK123

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

GB0002015021

 

 

b)

Nature of the transaction

Grant of a conditional share award under the Long-term Incentive Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

383,478

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A (single transaction)

e)

Date of the transaction

2024-03-27

 

f)

Place of the transaction

Outside a trading venue

 

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Mike Crowder

2

Reason for the notification

a)

Position/status

Group Managing Director and Executive Director (PDMR).

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

TClarke plc

b)

LEI

213800OIP8MU517BK123

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

GB0002015021

 

 

b)

Nature of the transaction

Grant of a conditional share award under the Long-term Incentive Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

326,877

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A (single transaction)

e)

Date of the transaction

2024-03-27

 

f)

Place of the transaction

Outside a trading venue

 

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Trevor Mitchell

2

Reason for the notification

a)

Position/status

Group Finance Director and Executive Director (PDMR).

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

TClarke plc

b)

LEI

213800OIP8MU517BK123

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

GB0002015021

 

 

b)

Nature of the transaction

Grant of a conditional share award under the Long-term Incentive Plan

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

287,668

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A (single transaction)

e)

Date of the transaction

2024-03-27

 

f)

Place of the transaction

Outside a trading venue

 

For further information contact:

TClarke plc

Mark Lawrence Group Chief Executive

Trevor Mitchell Finance Director

Tel: 020 7997 7400

 www.tclarke.co.uk

 

Cavendish Capital Markets Limited (Corporate Broker)

Ben Jeynes (Corporate Finance)

Tel: 020 7397 8900

 www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 551

 

27 March 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGZFFNRGDZM
Date   Source Headline
29th Jun 20227:00 amRNSNotice of Investor Presentation
23rd Jun 202210:45 amRNSNotice of Results
22nd Jun 20222:46 pmRNSChange of Auditor
22nd Jun 20229:37 amRNSTotal Voting Rights
17th May 20227:00 amRNSTClarke to Present at Mello Investor Conference
11th May 202210:27 amRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
10th May 202212:51 pmRNSESOT Share Purchase
5th May 20223:52 pmRNSESOT Share Purchase
3rd May 20229:03 amRNSDirector/PDMR Shareholding
26th Apr 20224:29 pmRNSVesting of EIP share awards April 2022
20th Apr 20229:27 amRNSChange of Registered Office
8th Apr 202210:09 amRNSPublication of Annual Report and Notice of AGM
8th Apr 20227:00 amRNSDirectorate Change
16th Mar 20228:27 amRNSDirector/PDMR Shareholding
16th Mar 20228:21 amRNSTotal Voting Rights
11th Mar 20227:00 amRNSInvestor Presentation
9th Mar 20227:02 amRNSDirectorate Change
9th Mar 20227:00 amRNSNotification of Investor Presentation
9th Mar 20227:00 amRNSFinal Results
2nd Feb 20223:21 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSNotification of Investor Presentation
27th Jan 20227:00 amRNSTrading Statement
4th Jan 202211:28 amRNSBlock listing Interim Review
9th Dec 20211:11 pmRNSESOT Share Purchase
6th Dec 20219:40 amRNSESOT Share Purchase
3rd Dec 202111:51 amRNSTR-1: Notification of Change of Holding
1st Dec 20213:02 pmRNSPDMR Disclosure
1st Dec 20213:00 pmRNSTotal Voting Rights and Share Capital
25th Nov 20217:00 amRNSTrading Statement
18th Oct 20217:00 amRNSInvestor Presentation
6th Oct 202111:14 amRNSPDMR Holding
6th Oct 202111:10 amRNSBlock Listing Application
22nd Sep 20217:00 amRNSNotice of Investor Presentation
17th Aug 20211:41 pmRNSDirector/PDMR Shareholding
9th Aug 20217:00 amRNSTClarke Selected for NHS Smart Buildings Framework
20th Jul 20217:00 amRNSHalf-year Report
5th Jul 20217:00 amRNSBlock listing Interim Review
1st Jul 20217:00 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
6th May 20219:04 amRNSTR-1: Notification of major holding in Company
5th May 202111:20 amRNSResult of AGM
5th May 20217:01 amRNSDirectorate Change
5th May 20217:00 amRNSAGM - Trading Update
29th Apr 20217:00 amRNSDirector / PDMR Shareholding
28th Apr 20217:00 amRNSDirector / PDMR Shareholding
12th Apr 202110:40 amRNSESOT Share Purchase
9th Apr 20212:53 pmRNSPublication of Annual Report & Notice of 2021 AGM
6th Apr 202110:39 amRNSESOT Share Purchase
26th Mar 20212:28 pmRNSESOT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.